Ncardia DiscoverHit Drug Screening Platform

Ncardia has launched the DiscoverHit drug screening platform, a service intended to help researchers access disease-relevant biology earlier in the drug-discovery process. DiscoverHit is a phenotypic drug screening platform comprising genetic and induced human pluripotent stem cell-derived cardiac and neural disease models; controlled bioreactor-based manufacturing to enable batch sizes compatible with high-throughput screening; customized development of disease-relevant assays; and high-throughput screening combined with high-content data acquisition and analysis.